NAS:MORF (USA) Also Trade In: Germany
Morphic Holding Inc $ 27.22 -1.44 (-5.02%)
Warning! GuruFocus has detected 1 Severe warning sign with MORF. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for MORF (Morphic Holding Inc) from 2019 to Oct 26 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Morphic Holding stock (MORF) PE ratio as of Oct 26 2020 is 0. More Details
Morphic Holding PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Morphic Holding PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:ATRA NAS:ASMB NAS:ARDX NAS:RTRX NAS:ADAP NAS:PRVB NAS:ZIOP NAS:AKRO NAS:GTHX NAS:KALA OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 35 Gatehouse Drive, A2, Waltham, MA, USA, 02451
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer.